Clinical Trial Update: Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the optimal antiplatelet therapy after left atrial appendage closure in dialyzed patients with atrial fibrillation. Recruitment is ongo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: National Institute of Cardiology, Warsaw, Poland | Conditions: Atrial Fibrillation | Phase 4 | Status: RECRUITING